Ciara Linnane

Jefferies analysts are advising “aggressively” buying Nike’s beaten-down stock.

If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.

SEC tells company not to use individually tailored accounting metrics or ones that may be misleading.

Bank’s stock trading rose 45% to $4.1 billion in latest quarter

23andMe has filed for bankruptcy protection just months after adding “going concern” language to its financials.

Mizuho lowers its price target by 16.5% to reflect all of the EV maker’s current woes.

Guess Inc.’s stock soared 30% on Monday after the maker of clothing, footwear and accessories said it received an offer from New York-based investment company WHP Global to take it private for $13 a share in cash.

Tesla has lost share to Chinese competitors, while Elon Musk’s political activities have led to steep declines in Tesla sales in Europe.

Mattel and Hasbro may be forced to raise prices if President Donald Trump’s 20% tariffs on imports from China remain in place, but both companies have mitigation strategies in place.

All eight analysts who cover the stock on FactSet have a buy rating. It’s all about the eggs.

Viking has found a manufacturing partner, removing a key overhang on the stock.

“Mr. McMullen’s conduct is not related to the company’s financial performance, operations or reporting, and it did not involve any Kroger associates,” the company said.

Versace would return to Italian ownership after it was acquired by Michael Kors in 2018.

The company will continue to invest in brands and supply-chain capabilities as it targets $1 billion in sales by 2027.

The company said it continues to “recover from the snack nuts supply disruption” that impacted Planters nuts.

More than 160 million birds have been culled during the bird-flu outbreak that started in 2022. So why is the U.S. not vaccinating chickens?

The parent company of Outback Steakhouse swings to a loss and offered soft guidance for 2025 amid continued pressure on fast-casual dining.

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

Snowflake shares soared in after-hours trade Wednesday, after the company’s fiscal fourth-quarter revenue topped estimates and it offered upbeat guidance for fiscal 2026.

Metsera’s GLP-1 peptide has a long half-life, meaning it could be administered once a month. The company is ready to scale up.